Advertisement

Topics

Takeda Pharmaceuticals North America, Inc. Company Profile

00:02 EST 19th November 2017 | BioPortfolio

Takeda Pharmaceuticals North America, Inc. is a new kind of pharmaceutical company. We are dedicated to serving patients by providing innovative products that improve their lives with better healthcare. With a foundation built on the tremendous success of ACTOS® (pioglitazone HCl) as well as a robust, early-stage pipeline, TPNA is poised to realize its vision of becoming a world class pharmaceutical company. Our unique culture sets us apart. At TPNA, we are committed to patients, our employees and the community. We have an innovative, entrepreneurial spirit combined with the rich history of our 220-year-old parent company.
Headquartered in Lincolnshire, Illinois, a northern suburb of Chicago, TPNA is a wholly owned U.S. subsidiary of Takeda Pharmaceutical Company Limited, Japan’s largest pharmaceutical company. With more than five years of service in the U.S., we have grown rapidly and each step of that growth remains true to the company’s integrity, heritage and people.

Location

475 Half Day Road
Lincolnshire
Illinois
60069
United States of America

Contact

Phone: 847-383-3000
Email: pr@tpna.com


News Articles [2203 Associated News Articles listed on BioPortfolio]

Takeda, Cardurion Pharmaceuticals partner on cardiovascular development

Takeda Pharmaceutical and Cardurion Pharmaceuticals announced the creation of a new cardiovascular development partnership. Cardurion, a recently launched Boston-area based biotechnology company, is f...

Hikma and Takeda sign new licensing agreement to expand product portfolio in MENA

Hikma Pharmaceuticals has reached an agreement with Takeda Pharmaceutical Company to expand their licensing and distribution agreement to add new products to its existing portfolio in the Middle East ...

Pharmaceuticals in North America [Report Updated: 30062017] Prices from USD $350

Pharmaceuticals in North AmericaSummaryPharmaceuticals in North America industry profile provides topline qualitative and quantitative summary information including: market share, market size value 20...

Takeda, Cardurion Pharmaceuticals Launch Cardiovascular Development Partnership

NewsCardurion is led by two physician scientists with extensive experience in cardiovascular science, medicine and drug development.

Takeda and SGC Announce a Collaboration Agreement Using Patient Tissue-Based Assays for ...

For SGC and KI:Michael Sundström, Scientific DirectorMichael.sundstrom@ki.se+46 79 65 44 662KI press office: +46 8 524 860 77orFor Takeda:Tsuyoshi Tada – Japantsuyoshi.tada@takeda....

Samsung Bioepis ventures into novel R&D with Takeda deal

Samsung Bioepis is joining forces with Takeda Pharmaceutical to jointly fund and co-develop multiple novel biologic therapies in unmet disease areas, taking its first step towards developing new pharm...

Takeda, Cardurion Pharmaceuticals form cardiovascular development partnership

Takeda Pharmaceutical and Cardurion Pharmaceuticals have created a new cardiovascular development partnership.

Prana partners with Takeda in Parkinson’s gastrointestinal neuropathology

Prana Biotechnology has entered into a research collaboration with Takeda Pharmaceuticals International to study the potential of its investigational movement disorders compound, PBT434, to slow or pr...

Drugs and Medications [572 Associated Drugs and Medications listed on BioPortfolio]

Prevacid [Novartis Consumer Health, Inc.]

PREVACID 24 HRLansoprazole delayed-release capsules 15mg / acid reducer

Tork premium [SCA Tissue North America]

TORK® Soap Foam Antibacterial

Tork premium hand sanitizer foam [SCA Tissue North America]

TORK Hand Sanitizer Foam

Tork premium hand sanitizer foam alcohol-free [SCA Tissue North America]

TORK® Hand Sanitizer Foam Alcohol-Free

Pro therapy md [Valeant Pharmaceuticals North America LLC]

PRO+ THERAPY MD™ ADVANCED ULTRA LIGHT DAY REPAIR SPF 30

PubMed Articles [1510 Associated PubMed Articles listed on BioPortfolio]

Historical and future trends in global source-receptor relationships of mercury.

Growing concern about the risk associated with increasing environmental mercury (Hg) concentrations has resulted in a focus on the relationships between intercontinental emitted and accumulated Hg. We...

The Paleo-Indian Entry into South America According to Mitogenomes.

Recent and compelling archaeological evidence attests to human presence ∼14.5 thousand years ago (Kya) at multiple sites in South America and a very early exploitation of extreme high-altitude Andea...

Second malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: A population-based study.

Few studies in North America have quantified the risks of second malignant neoplasms (SMNs) among survivors of childhood non-central nervous system (non-CNS) embryonal tumours due to their rarity. We ...

Transoral thyroidectomy and parathyroidectomy - A North American series of robotic and endoscopic transoral approaches to the central neck.

Most thyroid surgery in North America is completed via a cervical incision, which leaves a permanent scar. Approaches without cutaneous incisions offer aesthetic advantages. This series represents the...

North American matsutake: names clarified and a new species described.

Tricholoma matsutake, known widely as "matsutake," has great commercial and cultural significance in Japan. Because Japanese production is insufficient to meet the high domestic demand, morphologicall...

Clinical Trials [683 Associated Clinical Trials listed on BioPortfolio]

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant...

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

This is a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceut...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Sorafenib-RT in Treating Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. The incidence is highest in Asia and it is increasing in North America, with a two to three fold increase in mor...

Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants

The purpose of this study is to assess the bioavailability of dexlansoprazole from a 30 milligram (mg) or 60 mg delayed-release capsule manufactured at Takeda GmbH Plant Oranienburg, Germa...

Companies [3113 Associated Companies listed on BioPortfolio]

Mended Hearts and Takeda Pharmaceuticals North America, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharma...

Takeda Pharmaceutical North America, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharma...

Takeda Pharmaceuticals North America, Inc

Takeda Pharmaceuticals North America, Inc. is a new kind of pharmaceutical company. We are dedicated to serving patients by providing innovative products that improve their lives with better healthcar...

Takeda Pharmaceuticals International, Inc.

Located in Deerfield, Illinois, Takeda Pharmaceuticals International, Inc. is a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, an industry leader and the larges...

Takeda Pharmaceuticals North America

Takeda Pharmaceuticals North America, Inc. is a new kind of pharmaceutical company. We are dedicated to serving patients by providing innovative products that improve their lives with better healthcar...

More Information about "Takeda Pharmaceuticals North America, Inc." on BioPortfolio

We have published hundreds of Takeda Pharmaceuticals North America, Inc. news stories on BioPortfolio along with dozens of Takeda Pharmaceuticals North America, Inc. Clinical Trials and PubMed Articles about Takeda Pharmaceuticals North America, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Takeda Pharmaceuticals North America, Inc. Companies in our database. You can also find out about relevant Takeda Pharmaceuticals North America, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record